Study supports stent-shunt for refractory ascites
This article was originally published in Clinica
Executive Summary
Transjugular intrahepatic portosystemic stent-shunting is an effective treatment for patients with liver cirrhosis and refractory ascites, according to a German study. Researchers from Albert Ludwig University in Freiburg used J&J's Palmaz-Schatz stent and Schneider's Wallstent in 50 of 62 consecutive patients in an uncontrolled prospective study (New England Journal of Medicine, May 4th).